India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

Authorities are planning stricter penalties for retailers and wholesalers as part of efforts to clean up the pharma supply ...

Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...

Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

The Nifty Pharma Index has taken a hit, dropping nearly 2% in Friday’s trade. Over the last five days, the index has declined by approximately 4.3%, and on a year-to-date basis, it has fallen by ...

On Tuesday, Amazon Pharmacy announced that it now delivers medicines across all serviceable pin codes in the country, ...

The TRUST initiative follows India’s induction into the US-led Minerals Security Finance Network in September last year and ...